Exploring the molecular pathways of miRNAs in testicular cancer: from diagnosis to therapeutic innovations

Almstrup K, Lobo J, Mørup N, Belge G, Rajpert-De Meyts E, Looijenga LHJ, Dieckmann K-P (2020) Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat Rev Urol 17:201–213

Article  CAS  PubMed  Google Scholar 

Altieri DC (2013) Targeting survivin in cancer. Cancer Lett 332:225–228

Article  CAS  PubMed  Google Scholar 

Amiri BS, Sabernia N, Abouali B, Amini P, Rezaeeyan H (2023) Evaluation of microRNA as minimal residual disease in leukemia: diagnostic and prognostic approach: a review. Iran J Public Health 52:2541

PubMed  PubMed Central  Google Scholar 

Annese T, Tamma R, De Giorgis M, Ribatti D (2020) microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis. Front Oncol 10:581007

Article  PubMed  PubMed Central  Google Scholar 

Arif KMT, Elliott EK, Haupt LM, Griffiths LR (2020) Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets. Cancers 12(10):1–25

Aveta A, Cilio S, Contieri R, Spena G, Napolitano L, Manfredi C, Franco A, Crocerossa F, Cerrato C, Ferro M, Del Giudice F, Verze P, Lasorsa F, Salonia A, Nair R, Walz J, Lucarelli G, Pandolfo SD (2023) Urinary MicroRNAs as biomarkers of urological cancers: a systematic review. Int J Mol Sci 24:10846

Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R (2008) Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev 22:2773–2785

Article  CAS  PubMed  PubMed Central  Google Scholar 

Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A (2021) Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management. J Urol 205:137–144

Article  PubMed  Google Scholar 

Bagrodia A, Savelyeva A, Lafin JT, Speir RW, Chesnut GT, Frazier AL, Woldu SL, Margulis V, Murray MJ, Amatruda JF, Lotan Y (2021) Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours. BJU Int 128:57–64

Article  CAS  PubMed  Google Scholar 

Bailey S, Ferraresso M, Alonso-Crisostomo L, Ward D, Smith S, Nicholson JC, Saini H, Enright AJ, Scarpini CG, Coleman N (2023) Targeting oncogenic microRNAs from the miR-371~ 373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption. Br J Cancer 129:1451–1461

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barchi M, Bielli P, Dolci S, Rossi P, Grimaldi P (2021) Non-coding RNAs and splicing activity in testicular germ cell tumors. Life 11(8):736

Batool A, Wang Y-Q, Hao X-X, Chen S-R, Liu Y-X (2018) A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth. Cell Death Dis 9:962

Article  PubMed  PubMed Central  Google Scholar 

Baumann V, Winkler J (2014) miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents. Future Med Chem 6:1967–1984

Article  CAS  PubMed  Google Scholar 

Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, Dieckmann K-P (2024) Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study. Clin Cancer Res 30:404–412

Article  CAS  PubMed  Google Scholar 

Bleve S, Cursano MC, Casadei C, Schepisi G, Menna C, Urbini M, Gianni C, De Padova S, Filograna A, Gallà V, Rosti G, Barone D, Chovanec M, Mego M, De Giorgi U (2022) Inflammatory biomarkers for outcome prediction in patients with metastatic testicular cancer. Front Oncol 12:1–10

Boublikova L, Buchler T, Stary J, Abrahamova J, Trka J (2014) Molecular biology of testicular germ cell tumors: unique features awaiting clinical application. Crit Rev Oncol Hematol 89:366–385

Article  PubMed  Google Scholar 

Boyer A, Hermo L, Paquet M, Robaire B, Boerboom D (2008) Seminiferous tubule degeneration and infertility in mice with sustained activation of WNT/CTNNB1 signaling in sertoli cells. Biol Reprod 79:475–485

Article  CAS  PubMed  Google Scholar 

Budakoti M, Panwar AS, Molpa D, Singh RK, Büsselberg D, Mishra AP, Coutinho HDM, Nigam M (2021) Micro-RNA: The darkhorse of cancer. Cell Signal 83:109995

Article  CAS  PubMed  Google Scholar 

Cardenas RP, Zyoud A, McIntyre A, Alberio R, Mongan NP, Allegrucci C (2024) NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2. Stem Cell Res Ther 15:128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF (2008) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8:187–198

Article  CAS  PubMed  Google Scholar 

Chang H, Guillou F, Taketo MM, Behringer RR (2009) Overactive beta-catenin signaling causes testicular sertoli cell tumor development in the mouse. Biol Reprod 81:842–849

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang H, Yi B, Ma R, Zhang X, Zhao H, Xi Y (2016) CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep 6:22312

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chieffi P, De Martino M, Esposito F (2020) Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets. Expert Rev Anticancer Ther 20:189–195

Article  CAS  PubMed  Google Scholar 

Chuang JC, Jones PA (2007) Epigenetics and microRNAs. Pediatr Res 61:24r–29r

Article  CAS  PubMed  Google Scholar 

Collins AS, McCoy CE, Lloyd AT, O’Farrelly C, Stevenson NJ (2013) miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling. PLoS ONE 8:e69090

Article  CAS  PubMed  PubMed Central  Google Scholar 

Constâncio V, Tavares NT, Henrique R, Jerónimo C, Lobo J (2023) MiRNA biomarkers in cancers of the male reproductive system: Are we approaching clinical application? Andrology 11:651–667

Article  PubMed  Google Scholar 

Costache M, Ioana M, Iordache S, Ene D, Costache CA, Săftoiu A (2015) VEGF expression in pancreatic cancer and other malignancies: a review of the literature. Rom J Intern Med 53:199–208

CAS  PubMed  Google Scholar 

Cui M, Wang H, Yao X, Zhang D, Xie Y, Cui R, Zhang X (2019) Circulating MicroRNAs in Cancer: Potential and Challenge. Front Genet 10:626

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das MK, Furu K, Evensen HF, Haugen ØP, Haugen TB (2018) Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours. Sci Rep 8:2462

Article  PubMed  PubMed Central  Google Scholar 

Das MK, Evensen HS, Furu K, Haugen TB (2019) miRNA-302s may act as oncogenes in human testicular germ cell tumours. Sci Rep 9:9189

Article  PubMed  PubMed Central  Google Scholar 

Das MK, Haugen ØP, Haugen TB (2022) Diverse roles and targets of miRNA in the pathogenesis of testicular germ cell tumour. Cancers 14:1190

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Martino M, Esposito F, Pellecchia S, Cortez Cardoso Penha R, Botti G, Fusco A, Chieffi P (2020) HMGA1-regulating microRNAs Let-7a and miR-26a are downregulated in human seminomas. Int J Mol Sci 21:3014

Article  PubMed  PubMed Central  Google Scholar 

De Martino M, Chieffi P, Esposito F (2021) miRNAs and biomarkers in testicular germ cell tumors: an update. Int J Mol Sci 22:1380

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif